BSEAGM/EGM▲ PositiveResults29 Jul 2026
Alkem Laboratories Ltd
Please find attached herewith the Notice of AGM alongwith the Annual Report for the FY 2025-2026.
Alkem Laboratories Ltd has announced the Notice of 52nd Annual General Meeting (AGM) and Annual Report for FY 2025-2026. The AGM will be held on August 27, 2026, through Video Conferencing (VC)/ Other Audio-Visual Means (OAVM). The Annual Report highlights the company's growth journey, innovation, and diversification into new healthcare opportunities.
BSEOthersESG29 Jul 2026
Alkem Laboratories Ltd
Please find attached herewith the Business Responsibility and Sustainability Report for the financial year ended 31st March, 2026.
Alkem Laboratories Ltd has submitted its Business Responsibility and Sustainability Report for the financial year ended 31st March, 2026, as required by SEBI regulations.
BSEOthers29 Jul 2026
Alkem Laboratories Ltd
Please find enclosed herewith the Notice of the 52nd Annual General Meeting of the Company scheduled to be held on Thursday, 27th August, 2026 at 11.00 a.m. through Video Conferencing (VC)/ ....
Alkem Laboratories Ltd has announced the notice of its 52nd Annual General Meeting (AGM) scheduled for August 27, 2026, along with its annual report for the financial year 2025-2026.
BSECompany UpdateResults27 Jul 2026
Alkem Laboratories Ltd
Please find attached herewith intimation for Analyst / Investor Meet.
Alkem Laboratories Ltd. invites investors and analysts for a conference call on August 14, 2026, to discuss its Q1FY27 financial results.
BSECompany UpdateMgmt Change23 Jul 2026
Alkem Laboratories Ltd
Please find attached herewith Intimation regarding Resignation of Senior Management Personnel.
Alkem Laboratories Ltd has announced the resignation of Dr. Jitendra Singh Huda, a Senior Management Personnel, effective July 23, 2026, to pursue professional opportunities.
BSEBoard MeetingResults21 Jul 2026
Alkem Laboratories Ltd
Alkem Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 14/08/2026 ,inter alia, to consider and approve Please find attached herewith ....
Alkem Laboratories Ltd has informed BSE that the meeting of the Board of Directors is scheduled on 14/08/2026 to consider and approve the Standalone and Consolidated Unaudited Financial Results for the quarter ended 30/06/2026.